Stanford Journal of Law, Science & Policy (SJLSP)

SJLSP LogoThe Stanford Journal of Law, Science, and Policy is a peer reviewed journal for innovative interdisciplinary scholarship that bridges the divide between legal and scientific scholarship. The journal provides a unique opportunity for scientists and legal scholars to write together and is freely available online to ensure a broad readership.

Current Issue

Volume 7, Issue 1

Articles

Public-Private Partnerships to Promote Biosimilar Access, Affordability, and Patient Safety in Emerging Markets

Biosimilars have tremendous potential to reduce the costs of biologic therapies. Emerging markets may represent a significant fraction of future biosimilar production, development, and consumption. Yet safety concerns, price sensitivity, and lower quality standards represent challenges to public health in emerging markets. Well-crafted public-private partnerships between public health agencies, local biosimilar manufacturers, and global pharmaceutical firms that leverage advantages of each can result in biosimilar production targeted to local public health needs using a safety-focused infrastructure.
  • May 2014
  • 7 Stan. J.L. Sci. & Pol'y 1
  • Article

The Separation of Politics and Science

This article proposes that scientific inquiry regarding questions of fact should have an autonomous zone that is protected from politics. Although many scholars promote the idea that science is politicized, little empirical data exists to support this conclusion. This article contains an empirical study that demonstrates that the public received inaccurate information in the debate over a highly politicized and controversial area of scientific inquiry, embryonic stem cell research.

Read more about The Separation of Politics and Science
  • May 2014
  • 7 Stan. J.L. Sci. & Pol'y 10
  • Article

International Standards for Intellectual Property Protection of Neuroscience and Neurotechnology: Neuroethical Legal and Social (NELS) Considerations in Light of Globalization

With an increasingly globalized economy, the past 20 years have evidenced a trend towards global, uniform intellectual property standards through the advent of the World Trade Organization (WTO) and Trade Related Aspects of Intellectual Property (TRIPS). New TRIPS practices and increased levels of IP protection have had a significant effect on developing nations’ access to biomedical science and technologies. Moreover, while these agreements may afford prima facie recognition of the importance of public health, and allow compulsory licensing of implements essential to the public health, developing nations often face – and have externally-imposed – economic pressures that mitigate or prevent using these venues to acquire and employ state-of-the-art bioscientific capability.
  • May 2014
  • 7 Stan. J.L. Sci. & Pol'y 33
  • Article